Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HCAT | Common Stock | Options Exercise | $65.4K | +4.13K | +4.27% | $15.84 | 101K | Jan 5, 2022 | Direct | |
transaction | HCAT | Common Stock | Options Exercise | $105K | +6.62K | +6.57% | $15.84 | 107K | Jan 5, 2022 | Direct | |
transaction | HCAT | Common Stock | Sale | -$153K | -4.26K | -3.96% | $35.89 | 103K | Jan 5, 2022 | Direct | F1, F2 |
transaction | HCAT | Common Stock | Sale | -$186K | -5K | -4.84% | $37.15 | 98.2K | Jan 5, 2022 | Direct | F1, F3 |
transaction | HCAT | Common Stock | Sale | -$56.9K | -1.5K | -1.52% | $38.04 | 96.7K | Jan 5, 2022 | Direct | F1, F4 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HCAT | Stock Option (Right to Buy) | Options Exercise | $0 | -6.62K | -49.45% | $0.00 | 6.77K | Jan 5, 2022 | Common Stock | 6.62K | $15.84 | Direct | F5 |
transaction | HCAT | Stock Option (Right to Buy) | Options Exercise | $0 | -4.13K | -7.93% | $0.00 | 47.9K | Jan 5, 2022 | Common Stock | 4.13K | $15.84 | Direct | F6 |
Id | Content |
---|---|
F1 | The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 15, 2020, in accordance with Rule 10b5-1. |
F2 | Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $35.61 to $36.52, inclusive. |
F3 | Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $36.72 to $37.71, inclusive. |
F4 | Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $37.72 to $38.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) through (4). |
F5 | 25% of the 25,000 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on February 5, 2023. |
F6 | 25% of the 186,467 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on February 5, 2023. |